| |
| |
|
| Insider
Information: |
Onuscheck John Michael |
| Relationship: |
SVP & President, Europe |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
116,025 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,526,677 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
116,025 |
|
|
| Total
Value |
$8,526,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & President, Europe |
2015-01-01 |
116,025 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-08-02 |
4 |
D |
$5.54 |
$6,338 |
D/D |
(1,144) |
28,976 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
31,266 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2010-11-01 |
4 |
D |
$6.32 |
$5,309 |
D/D |
(840) |
30,426 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
D |
$7.60 |
$1,923 |
D/D |
(253) |
30,761 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
588 |
31,014 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,628 |
36,389 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-02-14 |
4 |
D |
$6.97 |
$16,519 |
D/D |
(2,370) |
34,019 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,061 |
39,080 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-02-16 |
4 |
D |
$7.10 |
$13,490 |
D/D |
(1,900) |
37,180 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-05-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,350 |
39,530 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-05-09 |
4 |
D |
$7.71 |
$6,646 |
D/D |
(862) |
38,668 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-07-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,167 |
42,835 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-07-29 |
4 |
D |
$7.16 |
$10,948 |
D/D |
(1,529) |
41,306 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-08-01 |
4 |
D |
$6.92 |
$7,916 |
D/D |
(1,144) |
43,280 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres-Neuromodulation |
• – – |
2011-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,118 |
44,424 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2011-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,290 |
45,570 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2011-10-31 |
4 |
D |
$5.81 |
$4,880 |
D/D |
(840) |
44,730 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
48,723 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-12 |
4 |
D |
$5.93 |
$10,022 |
D/D |
(1,690) |
47,033 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,638 |
48,671 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-13 |
4 |
D |
$5.94 |
$4,116 |
D/D |
(693) |
47,978 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-16 |
4 |
D |
$5.97 |
$12,782 |
D/D |
(2,141) |
50,897 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,060 |
53,038 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-28 |
4 |
D |
$6.36 |
$14,577 |
D/D |
(2,292) |
53,843 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & President, EMEA |
• – – |
2012-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,238 |
56,135 |
0 |
- |
|
79 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
